ORLANDO, Fla., Oct. 08, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of ...
ALLY is the first and only cataract laser to use artificial intelligence in the iris registration and surface identification of astigmatism management, as well as to automatically determine cataract ...
LENSAR, Inc. reported strong financial performance for Q4 and full-year 2024, highlighting an 86% increase in the placement of its ALLY Robotic Cataract Laser Systems, with a total of 31 systems ...
LensAR has announced cataract surgeons have completed the first laser cataract surgeries using the company’s LensAR laser system, according to a news release. Cataract surgeons David W. Shoemaker, MD, ...
ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR ®, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced laser solutions for the treatment of cataracts, today ...
Acquisition of ALLY Robotic Cataract Laser Systems strengthens Alcon’s cataract equipment and technology portfolio Next generation technology will be expanded globally, improving the efficiency of ...
Alcon ALC and LENSAR, Inc. LNSR, a global medical technology company focused on advanced laser solutions for the treatment of cataracts, recently entered into a definitive merger agreement. Per the ...
ORLANDO, Fla.--(BUSINESS WIRE)-- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced laser solutions for the treatment of cataracts, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback